Tae Min Kim Selected Research

Glioma (Gliomas)

1/2024	Added value of dynamic contrast-enhanced MR imaging in deep learning-based prediction of local recurrence in grade 4 adult-type diffuse gliomas patients.
6/2023	Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study).
1/2023	Deep learning based on dynamic susceptibility contrast MR imaging for prediction of local progression in adult-type diffuse glioma (grade 4).
11/2022	The telomere maintenance mechanism spectrum and its dynamics in gliomas.
4/2022	Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).
1/2022	Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.
1/2022	Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial.
1/2021	Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
4/2020	Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study).
1/2018	Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tae Min Kim Research Topics

Disease

107	Neoplasms (Cancer) 05/2024 - 03/2008
76	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 09/2011
23	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 07/2011
20	Lymphoma (Lymphomas) 01/2024 - 12/2012
17	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 03/2013
17	Neoplasm Metastasis (Metastasis) 09/2023 - 03/2008
16	Glioma (Gliomas) 01/2024 - 02/2011
13	Lung Neoplasms (Lung Cancer) 12/2023 - 08/2012
12	Squamous Cell Carcinoma of Head and Neck 08/2023 - 07/2013
10	Disease Progression 06/2023 - 01/2016
8	Melanoma (Melanoma, Malignant) 11/2023 - 11/2015
7	Adenocarcinoma 01/2019 - 05/2011
6	Adenocarcinoma of Lung 01/2023 - 04/2011
6	Brain Neoplasms (Brain Tumor) 04/2022 - 01/2015
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2023 - 06/2016
5	B-Cell Lymphoma (Lymphoma, B Cell) 07/2023 - 12/2014
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 10/2013
4	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 07/2006
4	Pneumonia (Pneumonitis) 02/2024 - 12/2013
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2023 - 10/2015
4	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 08/2023 - 05/2010
4	Infections 06/2023 - 04/2015
4	Extranodal NK-T-Cell Lymphoma 01/2023 - 07/2011
4	Diarrhea 04/2022 - 09/2014
4	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 07/2011
3	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 07/2004
3	Inflammation (Inflammations) 01/2024 - 11/2021
3	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 01/2023
3	Pruritus (Itching) 11/2023 - 04/2019
3	Exanthema (Rash) 11/2023 - 12/2014
3	Head and Neck Neoplasms (Head and Neck Cancer) 10/2023 - 01/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2023 - 02/2016
3	Hepatitis B 07/2023 - 06/2016
3	Carcinoma (Carcinomatosis) 12/2020 - 01/2015
3	Astrocytoma (Pilocytic Astrocytoma) 04/2020 - 04/2012
2	Neutropenia 02/2024 - 12/2012

Drug/Important Bio-Agent (IBA)

33	ErbB Receptors (EGF Receptor)IBA 12/2023 - 04/2011
31	Tyrosine Kinase InhibitorsIBA 10/2023 - 05/2011
22	Temozolomide (Temodar)FDA LinkGeneric 06/2023 - 07/2011
19	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2016
17	Anaplastic Lymphoma KinaseIBA 01/2022 - 05/2011
16	Rituximab (Mabthera)FDA Link 12/2023 - 09/2013
12	Biomarkers (Surrogate Marker)IBA 11/2023 - 09/2011
12	LigandsIBA 09/2023 - 09/2015
11	PlatinumIBA 12/2023 - 08/2012
11	Proteins (Proteins, Gene)FDA Link 09/2023 - 03/2008
11	Gefitinib (Iressa)FDA Link 01/2018 - 07/2013
10	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2023 - 11/2014
10	CrizotinibIBA 01/2022 - 06/2012
9	Vincristine (Oncovin)FDA LinkGeneric 06/2023 - 12/2012
8	pembrolizumabIBA 05/2024 - 01/2019
8	Prednisolone (Predate)FDA LinkGeneric 06/2023 - 08/2011
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2023 - 11/2014
7	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 07/2011
6	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 10/2012
6	RNA (Ribonucleic Acid)IBA 09/2023 - 01/2016
6	Pemetrexed (MTA)FDA Link 01/2019 - 09/2011
5	Monoclonal AntibodiesIBA 01/2024 - 01/2019
5	dabrafenibIBA 11/2022 - 01/2016
5	trametinibIBA 11/2022 - 07/2016
5	B7-H1 AntigenIBA 02/2021 - 11/2017
5	Methotrexate (Mexate)FDA LinkGeneric 03/2020 - 07/2014
4	mobocertinibIBA 10/2023 - 12/2021
4	Doxycycline (Periostat)FDA LinkGeneric 08/2023 - 05/2010
4	Prednisone (Sone)FDA LinkGeneric 01/2023 - 11/2014
4	Phosphotransferases (Kinase)IBA 01/2023 - 05/2015
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2022 - 07/2016
4	Etoposide (VP 16)FDA LinkGeneric 10/2019 - 11/2014
4	Ifosfamide FDA LinkGeneric 07/2018 - 12/2013
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 08/2013
4	Sunitinib (Sutent)FDA Link 09/2014 - 08/2011
3	Asparaginase (Elspar)FDA Link 01/2023 - 03/2015
3	polatuzumab vedotinIBA 01/2023 - 10/2020
3	BI 836826IBA 02/2021 - 10/2020
3	N-acetoacetyl-N-deacetylcolchicineIBA 01/2021 - 01/2014
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 01/2015
3	Brentuximab VedotinIBA 01/2021 - 06/2015
3	Docetaxel (Taxotere)FDA Link 01/2017 - 10/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 09/2011
3	Gemcitabine FDA Link 01/2015 - 08/2012
3	MethyltransferasesIBA 04/2013 - 10/2012
2	Therapeutic UsesIBA 05/2024 - 01/2018
2	SteroidsIBA 05/2024 - 01/2018
2	daratumumabIBA 01/2024 - 01/2021
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2024 - 11/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2023 - 07/2006

Therapy/Procedure

44	Therapeutics 05/2024 - 05/2010
44	Drug Therapy (Chemotherapy) 12/2023 - 07/2004
28	Radiotherapy 01/2024 - 07/2011
22	Chemoradiotherapy 04/2022 - 02/2011
8	Immunotherapy 11/2023 - 09/2015
6	Aftercare (After-Treatment) 10/2023 - 03/2014
6	Induction Chemotherapy 07/2016 - 07/2013
5	Combination Drug Therapy (Combination Chemotherapy) 06/2023 - 07/2004
4	Adjuvant Chemotherapy 01/2022 - 03/2008
3	Kidney Transplantation 12/2023 - 12/2016
3	Transplantation 10/2020 - 07/2006
2	Precision Medicine 05/2024 - 01/2020
2	Palliative Care (Palliative Therapy) 12/2023 - 01/2012
2	Terminal Care (Care, Terminal) 12/2023 - 01/2013